Skip to main content

Table 4 Covariance analysis of ORRs of clinical symptoms between the IFNα1b group and the control group after 7 days of treatment

From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial

 FASPPPSP
Statistics FStatistics F
Covariate effect0.5570.4570.3170.574
Sex comparison0.9290.3371.4930.224
Between-group comparison4.7810.0303.6490.048
Sex and Group0.0060.9410.0430.836